# Translational Neuropsychopharmacology Research of Nicotine Addiction

> **NCT02723162** · PHASE2 · COMPLETED · sponsor: **Medical University of South Carolina** · enrollment: 67 (actual)

## Conditions studied

- Nicotine Dependence, Cigarettes

## Interventions

- **DRUG:** Varenicline (VRN)
- **DRUG:** N-Acetylcysteine (NAC)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02723162
- **Lead sponsor:** Medical University of South Carolina
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05-04
- **Primary completion:** 2020-03-09
- **Final completion:** 2020-03-09
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2022-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02723162

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02723162, "Translational Neuropsychopharmacology Research of Nicotine Addiction". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02723162. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*